Related Experiment Video
Updated: Aug 14, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
[Progressive multifocal leukoencephalopathy confirmed by PCR for JC virus in cerebrospinal fluid: case report]
Alessandro Comarú Pasqualotto1, Alice J Z de Mattos, Marineide Melo Rocha
1Serviço de Infectologia, Hospital Nossa Senhora da Conceição, Porto Alegre, RS, Brasil. acpasq@terra.com.br
Abstract:
A case of progressive multifocal leukoencephalopathy (PML) is presented, with literature review. PML diagnosis and its differential diagnosis are presented, with emphasis on neuroradiology, cerebrospinal fluid analysis and polymerase chain reaction studies. The prognosis of PML is usually poor, with a median survival of 1-6 months. There is yet no proven effective treatment for this condition; HAART has become the standard of care for these patients.
Insights
Progressive multifocal leukoencephalopathy (PML) is a rare, often fatal brain infection. Diagnosis involves advanced imaging and lab tests, with no definitive cure but HAART as standard care.
Area of Science:
- Neuroimmunology
- Infectious Diseases
- Neurology
Background:
- Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease affecting the central nervous system.
- PML is caused by the JC virus (JCV) reactivation, typically in immunocompromised individuals.
Observation:
- This case report details a patient with PML, including a comprehensive literature review.
- Diagnostic approaches emphasized include neuroradiology, cerebrospinal fluid (CSF) analysis, and polymerase chain reaction (PCR) studies.
Findings:
- PML diagnosis and differential diagnosis are discussed, highlighting key distinguishing features.
- The prognosis for PML is generally poor, with a median survival of 1-6 months.
Implications:
- Current treatment options for PML are limited, with no universally effective therapy.
- Highly active antiretroviral therapy (HAART) is considered the standard of care for managing PML in eligible patients.
Related Concept Videos
Viral Meningitis
Arboviral Encephalitis
Cytomegalovirus Disease
Cryptococcal Meningitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology

